Skip to main content
261 results

In light of recent media attention, it is important to consider the risks and benefits associated with prescribing and taking montelukast for asthma treatment. While montelukast remains a valuable asthma treatment, for some, it is key to be aware of potential neuropsychiatric reactions.

Our second webinar in this series was held on Wednesday 28th February 2024.  Chaired by Dr Katherine Hickman (our PCRS Executive Chair), in conversation with Dr Mark Levy on the subject of asthma management, focusing on SABA over-reliance and how to address it.

In response to the BBC’s Morning Live segment broadcast 12th February on asthma, PCRS has formulated a joint response with the British Thoracic Society raising our concerns of the inaccurate reporting on asthma treatment.Our complaint in full: 

These sessions are tailored to healthcare professionals who are new to PCRS - you'll also have the opportunity to learn more about the work of PCRS and the benefits of becoming a member.

The start of a new year is an ideal time to support people to consider small ways to begin working towards a healthy lifestyle.

Spirometry is a component of the diagnosis and management of respiratory conditions in primary care and should ideally be performed via referral to a primary care network respiratory diagnostic service or community diagnostics centre (CDC) with expertise in the diagnosis of the most common respir

Primary care should seek to identify and provide proactive support to older people living with frailty.

In 2023, the Medicines and Healthcare Products Regulatory Agency (MHRA) approved the use of a dual (Inhaled corticosteroid/ Formoterol) combination treatment to be used as a reliever therapy for people aged 12 and over with the therapy choice situated early in the asthma treatment pathway as an a

Biologics are a class of medications that are specifically designed to target and modify specific components

As many as one-in-two healthcare attendances for breathing difficulties in Bradford could be triggered by breaches in daily air pollution limits, new research has uncovered. 

A new report is showcasing the impact of a national AHSN Network programme to improve access to FeNO testing for asthma diagnosis. Fractional exhaled Nitric Oxide (FeNO) tests are simple, non-invasive tests to support the diagnosis of asthma.

A new report is showcasing the impact of a national AHSN Network programme to improve access to FeNO testing for asthma diagnosis.

Viv Marsh (Asthma Nurse Specialist) is joined by Amanda Roberts (PCRS Patient Reference Group and PCRS Education Committee Patient Representative) to discuss all things Asthma Action Plans in this episode of the PCRS Podcast.